TerminatedNot Applicable

Feasibility of Omega-3 Supplementation for Children With Language Impairments

Stopped: Recruitment very difficult; only preliminary data usable.

Canada8 participantsStarted 2012-06

Plain-language summary

The primary objective of this study is to obtain preliminary (pilot) data regarding the feasibility of using dietary omega-3 supplementation in children with significant delays in language skills; a related secondary objective is to compare adherence to a dosage schedule of two easy-to-take formulations. A tertiary objective of this study is to collect preliminary (pilot) data pre- and post-supplementation to identify potential improvement of skills in a specific area of language development.

Who can participate

Age range24 Months – 42 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * children in the chronological age range of 24 to 42 months at the time of initial assessment * diagnosis of expressive, receptive or mixed language impairment (LI) by a certified Speech-Language Pathologist (S-LP) * ability to take daily omega-3 supplementation (with caregiver assistance) Exclusion Criteria: * children with any organic disease processes or genetic syndromes, or known developmental disorders such as autism that may present with language impairment * children with hearing impairment * children who take any non-standard dietary supplements (i.e., apart from multi-vitamins), particularly any omega-3 FA, prior to starting the study * children whose parents do not have an adequate understanding of English or French

What they're measuring

Change over 3 months in learning assessed by a fast-mapping task

Timeframe: Assessed at time of diagnosis and 3 months after intervention

Trial details

NCT IDNCT01640106

SponsorShuvo Ghosh

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-03